How digital health companies are capitalizing on the GLP-1 boom

Patent protection for Wegovy — Novo Nordisk’s blockbuster weight loss drug, which contains the second generation…

Eli Lilly to invest another $5.3 billion in Indiana plant to expand Mounjaro, Zepbound supply

An injection pen of Zepbound, Eli Lilly’s weight loss drug, is displayed in New York City…

This up-and-coming cancer treatment could be a $25 billion market opportunity — it’s already a hotbed for M&A

Skynesher | E+ | Getty Images Big pharma is betting billions on an up-and-coming class of…

AstraZeneca targets $80 billion in total revenue by 2030 in ‘post-Covid era’

The Astrazeneca logo is pictured at the World Artificial Intelligence Conference 2021 in Shanghai, China, July…

Healthy Returns: Eli Lilly, Novo Nordisk make progress toward boosting weight loss drug supply

An injection pen of Zepbound, Eli Lilly’s weight loss drug, is displayed in New York City,…

Wegovy maker Novo Nordisk extends losses following first-quarter results

Shares of Danish pharmaceutical giant Novo Nordisk slid 2.5% on Friday, extending a 2.7% loss on Thursday as…

Amgen stock soars on weight loss injection progress as Novo Nordisk, Eli Lilly shares slide

Pavlo Gonchar | Lightrocket | Getty Images Amgen‘s stock rose more than 12% on Friday after…

Amgen scraps experimental weight loss pill, moves forward with injection

The Amgen logo is displayed outside Amgen headquarters in Thousand Oaks, California, on May 17, 2023.…

Most people on weight loss drugs are spending less on restaurants and takeout, survey says

A food delivery messenger carries a take out bag outside aSweetgreen in Manhattan on September 14,…

Promise of Eli Lilly’s weight-loss drug for sleep apnea adds another reason to own the stock

Eli Lilly ‘s weight-loss drug Zepbound showed promise as a treatment for sleep apnea — giving…

Eli Lilly’s weight loss drug Zepbound shows promise as a sleep apnea treatment in late-stage trials

An injection pen of Zepbound, Eli Lilly’s weight loss drug, is displayed in New York City,…

Most doses of Eli Lilly’s Zepbound, Mounjaro in short supply through June, FDA says 

An injection pen of Zepbound, Eli Lilly’s weight loss drug, is displayed in New York City,…

Health care has had a tough year. Where we stand on our 5 stocks in the sector

There’s Eli Lilly (LLY), and then there’s everybody else. That’s a simple way to describe the…

Analysts predicted new obesity medicines would be blockbusters. Now they’re raising their forecasts

As new weight loss medications garnered buzz last year, analysts’ forecasts signaled these drugs would be…

Ozempic, Wegovy may curb drinking, smoking and other addictive behaviors – here’s what we know

An Ozempic (semaglutide) injection pen is seen on a kitchen table in Riga, Latvia on 06…

Newseum Global